01/17/2026
Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause mortality, hospitalization and other clinical health outcomes than those not using a GLP-1, according to study data. Samita Garg, MD, associate professor of medicine at Cleveland C...